SNY
Sanofi · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +2.9% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 517.20K | $21.14M | n/a | n/a |
| Q2 2026 | 111 | +6 | 144.61M | $6.22B | +8 | −2 |
| Q1 2026 | 107 | -7 | 161.36M | $7.80B | +3 | −10 |
| Q4 2025 | 113 | 0 | 171.90M | $8.37B | n/a | n/a |
| Q3 2025 | 17 | 0 | 119.31M | $5.63B | +1 | −1 |
| Q2 2025 | 14 | -1 | 113.96M | $5.51B | n/a | −1 |
| Q1 2025 | 13 | -1 | 114.44M | $6.35B | +1 | −2 |
| Q4 2024 | 14 | 0 | 106.76M | $5.15B | n/a | n/a |
| Q3 2024 | 13 | 0 | 105.96M | $6.11B | +1 | −1 |
| Q2 2024 | 13 | n/a | 103.00M | $5.00B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 76.30M | -1.1% | $4.40B | 2.5% | ▼ Trim | 2 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 13.36M | -1.8% | $769.89M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 5.75M | +209.0% | $331.51M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Wellington Management ✦ | 4.65M | -2.8% | $268.00M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 5 | Millennium Management ✦ | 2.74M | -13.0% | $158.12M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 1.12M | -0.1% | $64.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 766.00K | Nieuw | $44.14M | 0.1% | New | 1 | SEC ↗ |
| 8 | Soros Fund Management ✦ | 400.00K | +166.7% | $23.05M | 0.7% | ▲ Add | 2 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 341.86K | +8.0% | $21.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 254.74K | +7.0% | $14.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 175.59K | +40.0% | $10.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 88.88K | -58.0% | $5.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 13.48K | +90.1% | $776,704 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $44.14M | 0.1% |
Verlaten
| Viking Global Investors | $15.83M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 734 houders, 204.41M aandelen, $9.56B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.